Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
FDA's Marks Sees 'Two Or Three Year Window' To Transform Gene Therapy Environment
Apr 11 2023
•
By
Brenda Sandburg
FDA is focusing on ways to accelerate development of gene therapies • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Agency Leadership